Taken together, the IL6/STAT3/Acp5 pathway modulated the excitability of PrL pyramidal neurons to change the adaption of PrL region, which critically involved in the development of comorbidity of neuropathic pain/depression. The gene discussed is ACP5; the disease is depressive symptom measurement.